Qube Research & Technologies LTD Vericel Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Vericel Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 103,762 shares of VCEL stock, worth $4.98 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,762Holding current value
$4.98 Million% of portfolio
0.01%Shares
12 transactions
Others Institutions Holding VCEL
# of Institutions
268Shares Held
48.4MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$387 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$212 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$119 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.04MShares$98 Million1.42% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.27B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...